{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:16:28Z","timestamp":1778595388760,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2628-B-002-059"],"award-info":[{"award-number":["110-2628-B-002-059"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["111-2314-B-002-209"],"award-info":[{"award-number":["111-2314-B-002-209"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2326-B-002-003-MY3"],"award-info":[{"award-number":["110-2326-B-002-003-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW110-TDU-B-211-124002"],"award-info":[{"award-number":["MOHW110-TDU-B-211-124002"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["201606064RINB"],"award-info":[{"award-number":["201606064RINB"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 110-S4901"],"award-info":[{"award-number":["NTUH 110-S4901"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ijid.2023.01.035","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T03:02:37Z","timestamp":1675134157000},"page":"96-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection"],"prefix":"10.1016","volume":"129","author":[{"given":"Szu-Ting","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-6367","authenticated-orcid":false,"given":"Sung-Hsi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-3469","authenticated-orcid":false,"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chung","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.01.035_bib0001","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.45.2001628","article-title":"Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020","volume":"26","author":"Brinkwirth","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2023.01.035_bib0002","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.2147\/IDR.S206084","article-title":"Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: a systematic review and meta-analysis","volume":"12","author":"Jabbari Shiadeh","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2023.01.035_bib0003","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1017\/ice.2016.254","article-title":"Incidence and outcomes associated with infections caused by vancomycin-resistant enterococci in the United States: systematic literature review and meta-analysis","volume":"38","author":"Chiang","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ijid.2023.01.035_bib0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1586\/14787210.2015.1001839","article-title":"Therapeutic options for vancomycin-resistant enterococcal bacteremia","volume":"13","author":"Barber","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijid.2023.01.035_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1517\/14656560902811811","article-title":"Therapeutic options for infections due to vancomycin-resistant enterococci","volume":"10","author":"Wang","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0006","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijid.2023.01.035_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhm.994","article-title":"Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin","volume":"7","author":"Twilla","year":"2012","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ijid.2023.01.035_bib0009","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmii.2011.11.005","article-title":"Emergence of vancomycin-resistant Enterococcus bloodstream infections in southern Taiwan","volume":"45","author":"Chou","year":"2012","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2023.01.035_bib0010","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.cmi.2016.07.018","article-title":"Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose","volume":"22","author":"Chuang","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2023.01.035_bib0011","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jmii.2017.08.025","article-title":"Clinical characteristics and treatment outcomes of vancomycin-resistant Enterococcus faecium bacteremia","volume":"51","author":"Ye","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2023.01.035_bib0012","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/cid\/civ444","article-title":"Comparison of the effectiveness and safety of linezolid and daptomycin in vancomycin-resistant enterococcal bloodstream infection: A national cohort study of Veterans Affairs patients","volume":"61","author":"Britt","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0013","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jgar.2019.10.008","article-title":"Efficacy and safety of daptomycin versus linezolid treatment in patients with vancomycin-resistant enterococcal bacteraemia: an updated systematic review and meta-analysis","volume":"21","author":"Shi","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijid.2023.01.035_bib0014","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijantimicag.2016.06.010","article-title":"Similar efficacy and safety of daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bloodstream infections: a meta-analysis","volume":"48","author":"Zhao","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2023.01.035_bib0015","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12879-014-0687-9","article-title":"Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis","volume":"14","author":"Chuang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0016","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01289-13","article-title":"Systematic review and meta-analysis of linezolid versus daptomycin for treatment of vancomycin-resistant enterococcal bacteremia","volume":"58","author":"Balli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0017","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/mdr.2021.0333","article-title":"Risk factors associated with failure of linezolid therapy in vancomycin-resistant Enterococcus faecium bacteremia: a retrospective cohort study in a Referral Center in Mexico","volume":"28","author":"Lopez-Luis","year":"2022","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijid.2023.01.035_bib0018","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/345744","article-title":"Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program","volume":"36","author":"Birmingham","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0019","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1034\/j.1399-3062.2003.00024.x","article-title":"Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial","volume":"5","author":"El-Khoury","year":"2003","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0020","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/11319960-000000000-00000","article-title":"Pharmacological issues of linezolid: an updated critical review","volume":"49","author":"Di Paolo","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijid.2023.01.035_bib0021","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cid\/cix024","article-title":"Effect of daptomycin dose on the outcome of vancomycin-resistant, daptomycin-susceptible Enterococcus faecium bacteremia","volume":"64","author":"Chuang","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0022","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijantimicag.2014.05.010","article-title":"Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients","volume":"44","author":"Matsumoto","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2023.01.035_bib0023","article-title":"Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia","volume":"6","author":"Narayanan","year":"2019","journal-title":"Ther Adv Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0024","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2020"},{"key":"10.1016\/j.ijid.2023.01.035_bib0025","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/AAC.44.4.1062-1066.2000","article-title":"In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains","volume":"44","author":"Rybak","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0026","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1128\/AAC.00714-13","article-title":"Systematic review and meta-analysis of linezolid and daptomycin for treatment of vancomycin-resistant enterococcal bloodstream infections","volume":"57","author":"Whang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0027","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1017\/S0950268810002475","article-title":"Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents","volume":"139","author":"McKinnell","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ijid.2023.01.035_bib0028","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(20)31859-6","article-title":"Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2023.01.035_bib0029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00259-003-1341-8","article-title":"The kinetic basis of glomerular filtration rate measurement and new concepts of indexation to body size","volume":"31","author":"Peters","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijid.2023.01.035_bib0030","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1111\/bcp.15368","article-title":"Parametric population pharmacokinetics of linezolid: a systematic review","volume":"88","author":"Qin","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ijid.2023.01.035_bib0031","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/jac\/dky500","article-title":"Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia","volume":"74","author":"Xie","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0032","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1517\/13543784.2013.766716","article-title":"Weight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a phase I pharmacokinetic and pharmacodynamic study","volume":"22","author":"Cai","year":"2013","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.ijid.2023.01.035_bib0033","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/jcm9041067","article-title":"Linezolid concentrations in plasma and subcutaneous tissue are reduced in obese patients, resulting in a higher risk of underdosing in critically ill patients: a controlled clinical pharmacokinetic study","volume":"9","author":"Simon","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijid.2023.01.035_bib0034","doi-asserted-by":"crossref","first-page":"iv7","DOI":"10.1093\/jac\/dkr072","article-title":"Linezolid pharmacokinetics and pharmacodynamics in clinical treatment","volume":"66","author":"Dryden","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3947\/ic.2021.0034","article-title":"Optimization of linezolid dosing regimens for treatment of vancomycin-resistant enterococci infection","volume":"53","author":"Santimaleeworagun","year":"2021","journal-title":"Infect Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0036","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/AAC.00390-15","article-title":"In vitro activities of tedizolid and linezolid against Gram-positive cocci associated with acute bacterial skin and skin structure infections and pneumonia","volume":"59","author":"Chen","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0037","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/AAC.01194-06","article-title":"Pharmacokinetic\/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model","volume":"51","author":"Boak","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0038","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2010.02.019","article-title":"Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction","volume":"36","author":"Matsumoto","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2023.01.035_bib0039","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/00365548.2011.608712","article-title":"Correlation between serum linezolid concentration and the development of thrombocytopenia","volume":"44","author":"Hiraki","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2023.01.035_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijantimicag.2013.02.020","article-title":"Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections","volume":"41","author":"Cattaneo","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2023.01.035_bib0041","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2023.01.035_bib0042","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jfma.2020.06.011","article-title":"Impact of high plasma concentrations of linezolid in Taiwanese adult patients- therapeutic drug monitoring in improving adverse drug reactions","volume":"120","author":"Cheng","year":"2021","journal-title":"J Formos Med Assoc"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:25:55Z","timestamp":1778592355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"alternative-id":["S1201971223000358"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.01.035","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for mortality after linezolid treatment of vancomycin-resistant Enterococcus bloodstream infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.01.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}